Azimuth Capital Investment Management LLC
Position in NVS — Novartis AG
CIK 1942364
BLOOMFIELD HILLS, MI
Position in NVS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$244,094
+$23,778 QoQ
Shares Held
1,598
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Azimuth Capital Investment Management LLC holds $141,516,456 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,611 | $73,898,087 | |
| 2 | JNJ |
Johnson & Johnson
|
84,238 | $21,393,924 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
95,985 | $12,126,744 | |
| 4 | AZN |
Astrazeneca PLC
|
57,300 | $10,865,226 | |
| 5 | PFE |
Pfizer Inc
|
398,549 | $9,597,059 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
120,372 | $6,935,834 | |
| 7 | AMGN |
Amgen Inc
|
18,501 | $6,699,582 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $244,094 | 1,598 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $220,316 | 1,598 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||